ligands to form a heterodimer, which then led to the induction While testing for genotoxicity is usually performed on of teratogenic effects. A similar situation could be hypothesized single chemicals, exposure of humans always comprises a for other reactions (e.g. in carcinogenesis) that only occur if number of genotoxic agents. The investigation of potentially two distinct proteins are enabled to form an active complex synergistic effects of combinations therefore is an important by two specific compounds. issue in toxicology. Combinations of 511 keV γ-radiation Combination exposure to ionizing radiation and a chemical with the chemical alkylating agent ethyl methane-sulfonmutagen is not only of relevance for environmental mutagenesis ate were investigated in the in vitro micronucleus test in and carcinogenesis but is of interest also for combination mouse lymphoma L5178Y cells. With combinations in the cancer therapy, though with an opposing sign. Therefore, in low dose linear effect range for the individual agents (0.25-this paper we investigated the genotoxicity of two standard 2 Gy and 0.8-3.2 mM, respectively), supra-additivity by mutagens, γ-irradiation and the DNA alkylator ethyl methane-34-86% was seen. The synergism was more pronounced at sulfonate (EMS) in L5178Y mouse lymphoma cells. We chose the higher dose levels. Supra-additivity was confirmed in the formation of micronuclei as the genotoxicity end-point experiments using cytochalasin B and analyzing binucleate because the assay is simple, fast and reliable. The usefulness cells only, to control for putative effects on the cell cycle.
Introduction
Cells were cultured in suspension in RPMI 1640 supplemented with antibiotics, Humans are exposed to DNA-damaging agents as undefined 0.25 mg/ml L-glutamine, 107 µg/ml sodium pyruvate and 10% heat-inactivated mixtures. A combination of different carcinogens with possibly horse serum (all from Sigma Chemie GmbH, Deisenhofen, Germany). Cell different modes of action could result in an additive or noncultures were grown in a humidified atmosphere with 5% CO 2 in air at 37°C. additive (supra-or infra-additive) effect. Burkart and Jung In vitro micronucleus test (1998) 
recently published theoretical considerations about
Exponentially growing L5178Y mouse lymphoma cells were irradiated for a possible deviation from additivity of combinations of damaging short time (25-120 s) at room temperature with Cs radiation using a 511 keV agents. First of all they caution that synergism should not be Caesa-Gammatron (Siemens, Erlangen, Germany) . Dose rates were 0.6 Gy/min for 0.25 Gy and 1 Gy/min for 0.5, 1 and 2 Gy. EMS was added within 10 min postulated in situations termed 'isoaddition', as observed for after irradiation. EMS was prepared fresh as a 100ϫ stock solution in DMSO agents that act by the same mechanism and exhibit sublinear before addition to the cell cultures. The vehicle control contained a final cells was evaluated as a cell proliferation marker. Dose-response experiments and the combination experiment without cytochalasin B were performed three times, and one representative experiment is shown. The repeat experiments for the combination using the cytochalasin B protocol are all shown.
Statistical evaluation
For the testing of putative supra-additive or infra-additive effects of combination treatment, the data were evaluated with a 2-factor analysis of variance with interaction. The underlying model is described by the equation y ϭ ctr ϩ a ϩ b ϩ c ϩ d, where y is the observed micronucleus frequency, ctr is the control (solvent control) micronucleus frequency, a and b are the frequencies for the single treatments and c is the interaction term for simultaneous administration of the two treatments, describing the additional positive or negative effect obtained by simultaneous administration. Hence, the expected micronucleus frequency for simultaneous administration of the agents is ctr ϩ a ϩ b ϩ c. d is the error term accounting for the variation within groups. The error is assumed to have a normal distribution with mean 0 and identical standard deviation for all treatment groups. The P value is reported for the test of the hypothesis that c ϭ 0. It describes the probability that the observed difference between the effect of the mixture and the sum of the individual effects is different from 0 by chance alone. A P value of Ͻ0.05 is considered to represent significance.
Results
Using L5178Y mouse lymphoma cells we investigated the formation of micronuclei after treatment with γ-irradiation and EMS. From the individual dose-response curves ( Figure 1 ) we chose doses in the linear part of the dose-response effects for combination treatments. When we combined irradiation doses between 0.25 and 1 Gy with EMS concentrations between 0.8 and 3.2 mM, we found an induction of micronuclei that was higher than would be expected if the effects of both treatments were additive ( Figure 2 ). The extent of supraadditivity appeared to increase with dose and came close to a factor of 2.
Two questions could be raised that required further experiments. First, possible effects on cell cycle progression should be controlled for and, second, the detected supra-additivity needed statistical evaluation.
Therefore, we designed an experiment that included the use of cytochalasin B in the protocol. Cytochalasin B prevents cells from separating after mitosis, resulting in binucleate cells. The micronucleus evaluation could now be limited to the binucleate (i.e. actively proliferating) cell population in each treated cell culture, thus normalizing the micronucleus frequency to the progression of cell proliferation. Furthermore, the percentage of binucleate cells in the population was determined as a marker for cell proliferation changes. In this Percentages of binucleate cells showed that 0.5 Gy irradiation did not affect cell proliferation of L5178Y mouse lymphoma smaller effect of EMS in experiment b could be due to more cells compared with the solvent control while treatment with advanced degradation in the commercial batch used. 3.2 mM EMS caused a reduction in cell proliferation (Table  I , experiment a). The combination treatment also caused a Discussion reduction in proliferation which was similar to that induced by EMS alone. Thus, no supra-additive change in cell cycle Combination treatment with γ-irradiation and the DNA progression was observed. Micronucleus frequencies for the alkylating agent EMS exerted a supra-additive genotoxic effect combination treatment were again supra-additive compared in L5178Y mouse lymphoma cells with micronucleus formation with the single treatments. Statistical analysis revealed signichosen as the biological end-point. The over-additivity was ficance (P ϭ 0.002) for the supra-additivity of the group of demonstrated in several independent repeat experiments as combination treatments compared with the groups of single well as in one experiment that included independent replicates treatments. Two independent repeat experiments ( Table I, and allowed statistical analysis of the data. This result was experiments b and c) also showed supra-additive micronucleus obtained from doses within the linear part of the dose-response curves of the individual agents so that the supra-additivity is induction, to further support the results of experiment a. The Supra-additive genotoxicity of irradiation and EMS agents like EMS or γ-irradiation the probability of DNA damage becoming fixed as a heritable genetic change is dependent on the relative rates of DNA repair and cell division (Lutz, 1990) . These two processes can be regarded as rate limiting and it might be conceivable that irradiation and alkylation affect different rate limiting steps. In fact, it has been demonstrated that there is specificity for multiple G 2 /M cell cycle progression checkpoints in response to different types of DNA damage and that radiation induces a type of G 2 /M arrest that is different from that seen with most other stress stimuli, such as genotoxic chemicals (Abbott and Holt, 1999; Wang et al., 1999) .
Cell cycle control checkpoints and DNA repair have been shown to be important for micronucleus formation. We found in mutant hamster cell lines that a line with features of ataxia (Stopper et al., 1997) . The cell line used here, L5178Y mouse lymphoma, harbors a p53 tumor suppressor gene mutation (Storer et al., 1997) and p53 is known to be involved in cell cell cycle phase (G 2 /S phase), which increases the radioExperiment c sensitivity of this cell population (Tishler et al., 1992 inconclusive results (Preisler et al., 1998 , and references therein) and when induction of micronuclei was analyzed there Cells were treated with 0.5 Gy γ-irradiation and 3.2 mM EMS individually was no apparent deviation from additivity (Preisler et al., and in combination, using cytochalasin B for the production of binucleate cells. Micronucleus frequencies were determined in binucleate cells (BN 1999) . Recently other agents, such as mitomycin (Haffty et al., cells) . Each figure represents the mean of two slides from one culture dish 1997), have also been used in combination with radiation in with 1000 nuclei being evaluated on each slide.
cancer treatment. Based on our data it may be hypothesized Experiment a: 12 independent culture dishes (4ϫ3) were treated in parallel that alkylators may not only yield additive effects in treatment, within the same experiment.
but may in some cases act as radiosensitizers.
Experiments b and c: independent repeat experiments to experiment a (no replicates).
